small molecule

EPIDUO

ADAPALENE; BENZOYL PEROXIDE

Loss of exclusivityJuly 2027latest FDA-listed patent expiry
CompanyGALDERMA LABORATORIES LP

Drug detail

Brand nameEPIDUO
Active ingredientADAPALENE; BENZOYL PEROXIDE
Strength0.1%;2.5%
Dosage formGEL
RouteTOPICAL
ModalitySmall molecule
FDA approvalDecember 2008
Marketing statusRX

Listed patents

PatentExpiresType
8080537July 2027use U-1078
8129362July 2027use U-1078
8071644July 2027product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EPIDUO patent cliff — loss of exclusivity July 2027 | CliffBio